Mobile

An Open-Label, Multi-Centre, Extension Study, Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Patients with Prostate Cancer Requiring Androgen Ablation Therap...

Update Il y a 4 ans
Reference: EUCTR2006-006913-34

An Open-Label, Multi-Centre, Extension Study, Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Patients with Prostate Cancer Requiring Androgen Ablation Therapy

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate safety and tolerability during long-term treatment with degarelix one-month dosing regimen in prostate cancer patients

Inclusion criteria

  • Patients with histologically proven prostate cancer of all stages in whom endocrine treatment is indicated

Links